Djibouti - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Djibouti Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 40.8% year on year. In 2019, the country was ranked number 60 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 608 Cases. Djibouti is overtaken by Nepal, which was ranked number 59 at 635 Cases and is followed by Papua New Guinea at 580 Cases. India ranked the highest with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 608.00 |
| 2018 | 67.00 |
| 2017 | 91.00 |
| 2016 | 80.00 |
| 2015 | 85.00 |
How does Djibouti rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 59 |
#59
Nepal
|
635 | 2019 | -5.1 % | +9.4 % | View data | |
| 60 |
#60
Djibouti
|
608 | 2019 | +807.5 % | +40.8 % | View data | |
| 61 |
#61
Papua New Guinea
|
580 | 2019 | +34.0 % | +12.6 % | View data | |